Synthesis of nano liposomes used to treat cancer with personalized medicine technology based on the proteogenomics of cancer cells. 01212-16201, Teheran, Iran, September 2017, aangevraagd

G. Amoabediny; B.F. Haghiralsadat; M.N. Helder; B. Zandieh Doulabi; T. Forouzanfar

Synthesis of nano liposomes used to treat cancer with personalized medicine technology based on the proteogenomics of cancer cells. 01212-16201, Teheran, Iran, September 2017, aangevraagd

G. Amoabediny (Inventor)
, B.F. Haghiralsadat (Inventor)
, M.N. Helder (Inventor)
, B. Zandieh Doulabi (Inventor)
, T. Forouzanfar (Inventor)

Research output: Patent › Academic

Original language	English
Publication status	Published - 1 Sept 2017

Bibliographical note

M1 - 01212-16201

Persistent URL (handle)

Persistent link

Cite this

@misc{f0d0a484e7d2437e9ab9fb7a6d4bef29,

title = "Synthesis of nano liposomes used to treat cancer with personalized medicine technology based on the proteogenomics of cancer cells. 01212-16201, Teheran, Iran, September 2017, aangevraagd",

author = "G. Amoabediny and B.F. Haghiralsadat and M.N. Helder and \{Zandieh Doulabi\}, B. and T. Forouzanfar",

year = "2017",

month = sep,

day = "1",

language = "English",

type = "Patent",

}

TY - PAT

T1 - Synthesis of nano liposomes used to treat cancer with personalized medicine technology based on the proteogenomics of cancer cells. 01212-16201, Teheran, Iran, September 2017, aangevraagd

AU - Amoabediny, G.

AU - Haghiralsadat, B.F.

AU - Helder, M.N.

AU - Zandieh Doulabi, B.

AU - Forouzanfar, T.

N1 - M1 - 01212-16201

PY - 2017/9/1

Y1 - 2017/9/1

M3 - Patent

ER -